Outlook Therapeutics, Inc. Common Stock (NASDAQ: OTLK) last traded at $0.647, down 4.30% on the session. The quote above updates while this page is open; the figures below are drawn from Outlook Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Outlook Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker OTLK. Its market capitalisation is $157.56 million.
Valuation measures for Outlook Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $157.56M |
|---|---|
| Enterprise value | $182.89M |
| Price / sales | 111.46 |
| Beta | 0.86 |
Trailing-twelve-month figures tagged in Outlook Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $1.41M |
|---|---|
| Net income (TTM) | -$61.12M |
| Gross margin | 4.05% |
| Operating margin | -3935.93% |
| Cash | $11.24M |
Range and volume for OTLK over the past 52 weeks.
| 52-week high | $3.39 |
|---|---|
| 52-week low | $0.161 |
| Volume | 11.33M |
| Average volume | 27.04M |
| Previous close | $0.676 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.